ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$4.070
+$0.040 (+0.99%)
Day Range
$3.940 - $4.220
52 Week Range
$0.580 - $5.240
Volume
195.08K
Avg Volume (10D)
547.02K
Market Cap
$650.38M
Price Chart
Market Statistics
Open$4.020
Previous Close$4.030
Day High$4.220
Day Low$3.940
52 Week High$5.240
52 Week Low$0.580
Valuation
Market Cap650.38M
Shares Outstanding159.80M
Price to Book7.13
Trading Activity
Volume195.08K
Value Traded798.52K
Bid$4.040 × 2,000
Ask$4.190 × 1,750
Performance
1 Day-3.13%
5 Day-5.62%
13 Week-2.89%
52 Week560.66%
YTD-14.44%
Technical Indicators
RSI (14)56.88
50-Day SMA$3.378
200-Day SMA$2.971
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
